Sunday, 29 Nov, 2020


Russia seeks accelerated WHO registration for Sputnik V vaccine

Health Desk |
Update: 2020-10-28 12:19:13
Russia seeks accelerated WHO registration for Sputnik V vaccine Photo collected

The Russian Direct Investment Fund, (RDIF), the country’s sovereign wealth fund), has submitted applications to the World Health Organization (WHO) for accelerated registration (Emergency Use Listing, EUL) and prequalification for the world’s first registered vaccine against coronavirus, Sputnik V, which is based on a well-studied platform of human adenoviral vectors. 

The Russian Federation has become one of the first countries to apply to WHO for prequalification of its vaccine against COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2).

The Prequalification of Medicines Programme is a United Nations programme managed by WHO. 

It is the only global medicines quality assurance programme. The WHO prequalification of medicines assesses the quality, safety and efficacy of medicines. 

A medicinal product is included in the list of prequalified medicinal products subject to compliance with established requirements and standards of WHO.

“The Russian Federation was the first in the world to register a vaccine against the coronavirus, Sputnik V, which was created on a safe, effective and well-studied platform of human adenoviral vectors," Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said.

"We have submitted an application for Emergency Use Listing and prequalification of the vaccine by the World Health Organization, which will allow Sputnik V to be included in the list of medical products that meet leading quality, safety and efficacy standards," Kirill said.

"We express our gratitude to WHO for its active cooperation and look forward to the successful completion of the prequalification process at all major stages,” he added.

In the face of the ongoing pandemic, accelerated vaccine registration under the EUL procedure will make the Russian vaccine available globally in a shorter time frame than usual procedures and will support global efforts to prevent the coronavirus infection. 

Successful prequalification will enable Sputnik V to be included in the list of medicines used by international procurement agencies and countries to guide the bulk purchasing of medicines.

Source: Times Now News

BDST: 1218 HRS, OCT 28, 2020

All rights reserved. Sale, redistribution or reproduction of information/photos/illustrations/video/audio contents on this website in any form without prior permission from are strictly prohibited and liable to legal action.